Literature DB >> 23597439

Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.

Anna Bersano1, Michela Ranieri, Andrea Ciammola, Claudia Cinnante, Silvia Lanfranconi, Maria Teresa Dotti, Livia Candelise, Cinzaia Baschirotto, Isabella Ghione, Elena Ballabio, Nereo Bresolin, Maria Teresa Bassi.   

Abstract

Some missense mutations and small deletions in the NOTCH3 gene, not involving cysteine residues, have been described in patients considered to be affected by paucisymptomatic CADASIL. However, the significance of such molecular variants is still unclear. We describe a 49-year-old woman with a CADASIL-like phenotype, carrying a novel cysteine-sparing mutation in exon 29 of the NOTCH3 gene, and discuss the possible pathogenetic role of this molecular variant. Even though atypical clinical and MRI findings make a diagnosis of CADASIL unlikely in this patient, our report nevertheless underlines the intriguing genotype-phenotype relationship in NOTCH3 mutations and the importance of functional investigation to ascertain the role of new NOTCH3 mutations in CADASIL pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23597439      PMCID: PMC3861349     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  25 in total

1.  Diagnostic strategies in CADASIL.

Authors:  H S Markus; R J Martin; M A Simpson; Y B Dong; N Ali; A H Crosby; J F Powell
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

2.  Evaluation of diagnostic NOTCH3 immunostaining in CADASIL.

Authors:  Saskia A J Lesnik Oberstein; Sjoerd G van Duinen; Rivka van den Boom; Marion L C Maat-Schieman; Mark A van Buchem; Hans C van Houwelingen; Ingrid M Hegeman-Kleinn; Michel D Ferrari; Martijn H Breuning; Joost Haan
Journal:  Acta Neuropathol       Date:  2003-05-17       Impact factor: 17.088

3.  Diagnostic value of ultrastructural skin biopsy studies in CADASIL.

Authors:  A Malandrini; C Gaudiano; S Gambelli; G Berti; G Serni; S Bianchi; A Federico; M T Dotti
Journal:  Neurology       Date:  2007-04-24       Impact factor: 9.910

4.  Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis.

Authors:  A Joutel; P Favrole; P Labauge; H Chabriat; C Lescoat; F Andreux; V Domenga; M Cécillon; K Vahedi; A Ducros; F Cave-Riant; M G Bousser; E Tournier-Lasserve
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

5.  Cysteine-sparing notch3 mutations: cadasil or cadasil variants?

Authors:  Aldo Quattrone; Rosalucia Mazzei
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

6.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and CADASIL-like disorders in Japan.

Authors:  M Uchino; T Hirano; E Uyama; Y Hashimoto
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

7.  Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains.

Authors:  M Dichgans; H Ludwig; J Müller-Höcker; A Messerschmidt; T Gasser
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

8.  Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals.

Authors:  Poneh Adib-Samii; Glen Brice; Roswell J Martin; Hugh S Markus
Journal:  Stroke       Date:  2010-02-18       Impact factor: 7.914

9.  Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain.

Authors:  Charles Fouillade; Hugues Chabriat; Florence Riant; Manuèle Mine; Minh Arnoud; Laurent Magy; Marie Germaine Bousser; Elisabeth Tournier-Lasserve; Anne Joutel
Journal:  Hum Mutat       Date:  2008-03       Impact factor: 4.878

10.  Genetic, clinical and pathological studies of CADASIL in Japan: a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis.

Authors:  Yo Santa; Eiichiro Uyama; De Hua Chui; Masakuni Arima; Satoshi Kotorii; Keikichi Takahashi; Takeshi Tabira
Journal:  J Neurol Sci       Date:  2003-08-15       Impact factor: 3.181

View more
  11 in total

Review 1.  CADASIL: Treatment and Management Options.

Authors:  Anna Bersano; Gloria Bedini; Joshua Oskam; Caterina Mariotti; Franco Taroni; Silvia Baratta; Eugenio Agostino Parati
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

2.  Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014.

Authors:  Akihiko Ueda; Mitsuharu Ueda; Akihito Nagatoshi; Teruyuki Hirano; Takaaki Ito; Nobutaka Arai; Eiichiro Uyama; Kota Mori; Masaaki Nakamura; Satoru Shinriki; Katsuyoshi Ikeda; Yukio Ando
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

3.  A series of Notch3 mutations in CADASIL; insights from 3D molecular modelling and evolutionary analyses.

Authors:  Dimitrios Vlachakis; Spyridon Champeris Tsaniras; Katerina Ioannidou; Louis Papageorgiou; Marc Baumann; Sophia Kossida
Journal:  J Mol Biochem       Date:  2014

4.  Vascular cognitive impairment associated with NOTCH3 Exon 33 mutation: A case report.

Authors:  Yong Sun; Yan-Jun Wei; Ying Xing
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 5.  Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome.

Authors:  Vo Van Giau; Eva Bagyinszky; Young Chul Youn; Seong Soo A An; Sang Yun Kim
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

Review 6.  Genetic architecture of common non-Alzheimer's disease dementias.

Authors:  Rita Guerreiro; Elizabeth Gibbons; Miguel Tábuas-Pereira; Celia Kun-Rodrigues; Gustavo C Santo; Jose Bras
Journal:  Neurobiol Dis       Date:  2020-05-19       Impact factor: 5.996

7.  Potential New Cysteine Sparing Mutation in the NOTCH3 Gene in a Patient with Nonfamilial CADASIL-like Disease.

Authors:  Adnan I Qureshi; Muhammad T Khan; Omer Naveed; Muhammad A Saleem
Journal:  J Vasc Interv Neurol       Date:  2017-12

8.  Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke.

Authors:  Laura L Kilarski; Loes C A Rutten-Jacobs; Steve Bevan; Rob Baker; Ahamad Hassan; Derralynn A Hughes; Hugh S Markus
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

9.  A novel cysteine-sparing NOTCH3 mutation in a Chinese family with CADASIL.

Authors:  Wei Ge; Hanzhe Kuang; Bin Wei; Le Bo; Zhice Xu; Xingshun Xu; Deqin Geng; Miao Sun
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

Review 10.  Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL.

Authors:  Elena Muiño; Cristina Gallego-Fabrega; Natalia Cullell; Caty Carrera; Nuria Torres; Jurek Krupinski; Jaume Roquer; Joan Montaner; Israel Fernández-Cadenas
Journal:  Int J Mol Sci       Date:  2017-09-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.